Clinical trial

Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)

NCT00338260

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1995-06-01

PhasePHASE3

Study timeline

Study start (unknown)1995-06-01Date precision: month

Registry last updated2022-02-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)unresolved

Interventions

MK0954, /Duration of Treatment : 5 YearsDRUG

Comparator : atenolol /Duration of Treatment : 5 YearsDRUG

Sponsors & collaborators

Organon and Colead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00338260 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.